Subsequently, to investigate the role of PRMT2 in RCC metastatic ability in vivo, the same number of ACHN-shCtrl or ACHN-shPRMT2 cells was injected into BALB/c nude mice through the tail vein. This evidence concerns the gene PRMT2 and renal cell carcinoma.